spacer
home > pmps > winter 2001 > the latest developments in the scottish biotechnology industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Latest Developments in the Scottish Biotechnology Industry

Ardana Bioscience, the Edinburgh-based pharmaceutical company that specialises in reproductive health, and its Chief Executive Officer, Simon Best, have scooped two biotechnology industry awards. Ardana was voted 'Best New Biotechnology Company 2001' by its peers in the Scottish life sciences community, and Simon Best was also recognised individually for his significant contribution to the sector.


Simon Best was previously CEO of Roslin Bio-Med where he led the merger of Roslin Bio-Med with Geron Corporation, a leader in stem cell technology. In 1999, he was selected as a Global Leader for Tomorrow by the World Economic Forum and was awarded the title 'Science and Technology Venturer of the Year' by the Financial Times, British Venture Capital Association and Cartier.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kindeva Drug Delivery, Formerly 3M Drug Delivery Systems, Launches as an Independent Company

Kindeva is a leading global contract development and manufacturing organization (CDMO) that specializes in solving complex drug delivery challenges for its pharmaceutical and biotechnology customers. With approximately 900 employees, Kindeva serves customers with a wealth of expertise in formulation, product development and manufacturing. Kindeva-developed and manufactured therapies treat patients battling a host of debilitating and chronic diseases, including respiratory illnesses and cardiovascular conditions. The company's microneedle-based drug delivery platforms are currently being utilized in dozens of development programs, including programs for osteoporosis, immunotherapies, COVID-19 vaccines, and other difficult-to-deliver therapies.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement